Ceritinib

Zykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic non-small cell lung cancer. Each tablet contains 150 mg of ceritinib. This information was generated using AI and is provided for informational and research purposes only.